Tax and inflation issues related to corporations.
Privacy legislation related to biopharmaceutical manufacturers; Food and Drug Administration issues related to biopharmaceutical manufacturers; National security issues related to biopharmaceutical manufacturers; Public-private contracts for innovation in the biopharmaceutical space; National Defense Authorization Act; Issues related to step therapy; Issues related to health extenders; Issues related to Pandemic Preparedness and Response Program.
Medicare and other drug pricing issues relating to biopharmaceutical manufacturers.
Patent issues relating to biopharmaceutical manufacturers; Intellectual property legislation related to biopharmaceutical manufacturers; Issues relating to WTO TRIPS waivers.
Trade and tariff issues related to corporations.